Viewing Study NCT05110261


Ignite Creation Date: 2025-12-24 @ 12:17 PM
Ignite Modification Date: 2025-12-26 @ 6:47 AM
Study NCT ID: NCT05110261
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-26
First Post: 2021-10-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module